Find your next paid study

~$150 – $3,000

Actual pay is set by the research site.

Mayo ClinicNCT07556484

Effect of Cannabis Use on Synaptic Density in Older Adults

The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.

Cannabis Use

Yale UniversityNCT05465538

~$500 – $7,500

Actual pay is set by the research site.

A Randomized, Double-blind, Sham-controlled, Parallel-group Trial Designed to Evaluate the Efficacy of BreEStim in Managing Neuropathic Pain After SCI - a Pre-trial Study

The overall goal is to evaluate the effectiveness of different stimulation protocol of a novel intervention - Breathing-controlled electrical stimulation (BreE…

Neuropathic Pain

The University of Texas Health Science Center, HoustonNCT07878429

~$10 – $750

Actual pay is set by the research site.

Personalizing Multifocal Transcranial Direct Stimulation Dose to Target the Motor Network in Older Adults

The purpose of this study is to understand how the brain controls movement and how Non-invasive Brain Stimulation (NIBS) with a technique called High-density t…

Healthy

University of MichiganNCT06561165

~$10 – $750

Actual pay is set by the research site.

Phase 2

A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, With and Without an Anti-EGFR Antibody, and With an Anti-EGFR Antibody and Chemotherapy, in Patients With Metastatic KRAS G12D-Mutated Colorectal Adenocarcinoma (TARGET-D 203)

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab or panitumumab and cetuximab plus mFOLFOX in patients with me…

Colorectal Cancer

Verastem, Inc.NCT07659795

~$75 – $2,800

Actual pay is set by the research site.

Phase 3

A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the effica…

Crohn's Disease

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07184931

Recurrent Glioblastoma IDH Wildtype

Clinical Trial of D2C7-IT + 2141-V11 Combination Immunotherapy Administered Via Convection Enhanced Delivery in Non-enhancing Tumor Post-resection of Recurrent Glioblastoma, Followed by Cervical Perilymphatic Subcutaneous Injections of 2141-V11

The purpose of this study is to assess the safety and efficacy of the combination of D2C7-IT+2141-V11 administered in the non-enhancing tumor of patients with …

~$150 – $4,500

Actual pay is set by the research site.

Darell BignerNCT06455605

Sickle Cell Disease, Hemolytic Anemia

A Phase 1 Study to Evaluate the Safety and Tolerability of Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Background: Sickle cell disease (SCD) is an inherited blood disorder. The disease affects the ability of red blood cells to carry oxygen. Research has shown t…

National Heart, Lung, and Blood Institute (NHLBI)NCT07566494

~$150 – $2,700

Actual pay is set by the research site.

Characterization of the Nociception Phenotype in Individuals With Intellectual Disability

Background: People with intellectual disability (ID) often have physical disabilities as well. These physical problems can affect their bones, muscles, nerves…

Intellectual Disability

National Institutes of Health Clinical Center (CC)NCT05473429

~$10 – $675

Actual pay is set by the research site.

Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection

Background: Malaria is a serious disease caused by parasites spread by mosquitoes. To better diagnose and treat malaria, researchers need to learn more about …

Healthy VolunteerMalaria

National Institute of Allergy and Infectious Diseases (NIAID)NCT07859800

~$10 – $675

Actual pay is set by the research site.

Adrenocortical Carcinoma (ACC)Recurrent Adrenocortical Carcinoma (ACC)Recurrent Abdominal Adrenocortical Carcinoma (ACC)+2 more

A Phase I Dose-escalation Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Background: Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal glands. ACC often returns after tumors are removed with surgery. Less than 35% of p…

National Cancer Institute (NCI)NCT06487481

~$150 – $2,700

Actual pay is set by the research site.

Systemic Lupus ErythematosusRheumatoid Arthritis

A Phase 1, First-in-Human, Single Ascending Dose, Open-label, Non-randomized Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of ABBV-519 in Subjects With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inf…